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The consumption of Silkworm, Anaphe venata has been reported to be associated with a high incide e 
of seasonal ataxia in some parts of Nigeria. Injection of some doses of Aqueous Anaphe venata extract (AAV) 
by intraperitoneal route into mice has been reported to cause some behavioral changes associated with ataxia. 
We administered some doses of the extract (50–300 mg/kg) to mice orally in view of finding its effects on their 
fecal pellet output and elucidating the mechanism of action of the extract in the intestine of the mice. The 
extract caused a significant increase in fecal pellet weight and intestinal transit which was not dose-dependent. 
Doses of 200 and 300 mg/kg of the extract caused more significant reversal of loperamide-induced constipation 
than castor oil. Chlorpheniramine nifedipine and promethazine (1 mg/kg) blocked the increased fecal pellet 
output induced by the extract, while atropine and hexamethonium (1 mg/kg) did not block this effect of the 
extract. We concluded that AAV increased fecal pellet output of mice by increasing the peristaltic waves in 
their intestine via stimulation of H1 receptors and opening of L-type calcium channels and not through the 
cholinergic receptors.  
© 2011 International Formulae Group. All rights reserved. 
 




Worms and insects are very common 
delicacies in developing countries of the 
world, due to their accessibility, affordability 
and high protein content (Ene, 1963; De 
Follart, 1989, 1992). 
Anaphe Venata larvae (African 
Silkworm) is one of the worms that are eaten 
by people in the Western and Middle Belt 
regions of Nigeria as components of soup or 
refreshment items in restaurants, because they 
are very rich in protein (Umoh et al., 1980; 
Ashiru, 1988). The worms have also been 
shown to contain amino acids, fats and sterols 
(Onayade et al., 2004). Seasonal ataxia 
associated with consumption of these larvae 
has been reported (Adamolekun, 1992). 
Studies in mice confirmed that both polar and 
R. O. AKOMOLAFE et al. / Int. J. Biol. Chem. Sci. 5(6): 2371-2381, 2011 
 
 2372 
non-polar extracts of these worms, induced 
increase in behavioural components as tremor, 
jerking and stretching after intraperitoneal 
administration of the extractions for 7 days, an 
indication of Ataxia syndrome (Iwalewa et al., 
2005)  
However, there is a dearth of 
information on the effects of these worms on 
the intestine, the route through which they are 
taken into the body. The study was carried out 
to find the effect of the aqueous extract of 
Anaphe venata (AAV) on defecation in mice 
and to elucidate the mechanisms of action of 
the extract. 
 
MATERIALS AND METHODS 
Preparation of A. venata extract 
Dried Anaphe venata larvae were 
purchased from a market in Ile Ife, Osun 
State, Nigeria and authentication was done by 
Professor W. A. Muse in the Department of 
Zoology, Obafemi Awolowo University, Ile 
Ife. 
The powdered larvae (150 g) were 
extracted cold in 2 liters of distilled water 
with continuous shaking for 24 hours in a 
mechanical shaker. The mixture was filtered 
and then freeze dried to obtain the aqueous 
extract. The total aqueous extract obtained 
was 6.5 g (4.3% yield w/w). Chemical 
analysis of the extract was carried out in the 
Chemistry Department of Benue State 




Swiss mice of both sexes (25-30 g) 
were used for the experiments. Prior to the 
experiments, the animals were housed under 
standard controlled environmental conditions 
with a 12 hour light/dark cycle and with food 
(Pfizer Feed Plc, Nigeria) and water provided 
ad libitum. The mice were kept in plastic 
cages whose floors were lined with white 
blotting paper. Wire gauze was placed about 2 
cm above the papers so as to prevent the mice 
from eating up the papers. The mice were 
placed on the wire gauze for two weeks before 
the experiment in order to allow them to be 
familiar with the environment. The care and 
use of the animals and the experimental 
protocol of this study were in accordance with 
Experimental Animal Care and Use 
Regulation of the Animal House, College of 
Health Sciences, Benue State University, 
Makurdi, Nigeria which were also in 
accordance with the internationally accepted 
principles for laboratory animal use (EEC 
Directive of 1986; 86/609/EEC).  For all the 
experiments, the animals were fasted for 16 
hours before treatment. 
 
Drugs and treatments 
Nifedipine (NIF) was purchased from 
Medrel Pharmaceutical (India) PVT Ltd. 
Chlopheniramine (CHL), Atropine sulphate 
(ATR), Promethazine (PRO), Hexamethonium 
(HEX), Activated Charcoal, Sodium Chloride, 
Castor oil (CO) were obtained from Sigma 
Chemical Company, USA. All drugs and 
extract were dissolved in normal saline (0.9% 
sodium chloride solution) before being 
administered to mice.  
 
Effects on fecal pellet output 
Thirty mice were used for this aspect of 
the study. They were divided into six groups 
of five mice each. Each mouse was put in a 
separate cage. Each of Group 1 mice which 
served as the positive control was given 0.25 
ml (p.o.) of normal saline (NS). Group 2, the 
negative control, got 3 mg/kg CO each. Each 
mouse in groups 3-6 received 0.25 ml of AAV 
equivalent to 50, 100, 200 and 300 mg/kg of 
the extract respectively, a modification of the 
method of Ojewole et al. (2008). The fecal 
pellets of each mouse were counted every 2 
hours from the time of treatment for the first 8 
hrs and then overnight (24 hours), so as to 
assess their recovery. The presence of wet 
feces was also noted for each group. The 
pellets were air dried for another 24 hours 
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before weighing. The average of the number 
and weight of the pellets was taken as the 
output for each mouse in the group. 
 
Effects on loperamide induced constipation  
The two doses of AAV that produced 
the greatest fecal pellet weights (200 and 300 
mg/kg) were used as the Working Dose for 
this study. Twenty mice of both sexes were 
divided into four groups of five mice each. 
Group 1 received 0.25 ml NS by oral 
administration. Groups 2-4 received 10 mg/kg 
of loperamide each (p.o.). Thirty minutes 
later, group 2 received 3 ml/kg castor oil each, 
while each mouse in groups 3 and 4 got 200 
and 300 mg/kg AAV respectively. The fecal 
pellet output of each group was also recorded 
as stated in the first experiment above. 
 
Effects of some receptor blockers on AAV- 
induced defecation  
The dose of AAV that consistently 
produced the highest number and weight of 
fecal pellets and provided the greatest 
protection against loperamide-induced 
constipation (200 mg/kg) was selected as the 
Working Dose for this experiment. Thirty 
mice were used for this study. They were 
divided into six groups of 5 mice each. Group 
1 was pre-treated with 0.25 ml NS (i.p.), while 
groups 2–6 were given 1 mg/kg of the 
receptor blockers written against their names 
by intraperitoneal route as follows: group 2 
(ATR), group 3 (CHL), group 4 (PRO), group 
5 (NIF) and group 6 (HEX). Twenty minutes 
later, each animal was administered 200 
mg/kg AAV (p.o.) and the fecal pellet output 
was recorded as in the first experiment. 
 
Effects on intestinal transit 
The method of Gamaliel et al., (1996) 
was used. Thirty mice were divided into six 
groups of 5 mice each. Group 1 was given 
0.25 ml (p.o) of NS each. Group 2 received 
3ml/kg CO (p.o.) each. Groups 3-6 received 
0.25ml of AAV equivalent to 50,100,200 and 
300 mg/kg respectively. After 30 minutes, the 
animals were given 0.1 ml of freshly prepared 
charcoal meal (10% in NS) orally. Thirty 
minutes after charcoal meal administration, 
the mice were anaesthetized with chloroform. 
They were sacrificed by cervical dislocation 
and the abdomen immediately cut open to 
dissect out the whole small intestine (pylorus 
region to caecum). The length of the small 
intestine and the distance between the pylorus 
region and the front of the charcoal meal was 
measured for obtaining the charcoal transport 
ratio or percentage, that is the percentage of 
the entire small intestine travelled by the 
charcoal meal after 30 minutes. 
 
Statistical analysis 
Each value was expressed as mean ± 
SD. Significant changes in number and weight 
of fecal pellets and the distance travelled by 
charcoal meal along the small intestine 
following various  treatments were analyzed 
using one-way analysis of variance (ANOVA) 
followed by Tukey-Kramer Multiple 
Comparisons Test. P-value equal to or less 
than 0.05 was taken as significant. Data 
management was carried out using GraphPad 




Effects of AAV on the number of fecal 
pellets 
The effect of the doses of AAV used in 
this study (50–300 mg/kg) on the number of 
fecal pellets produced by the mice was not 
dose–dependent (Table 1).Only 200 mg/kg of 
AAV produced a significantly higher number 
of fecal pellets than NS throughout the study. 
It also caused significantly higher number 
fecal pellets than CO except at the fourth hour 
of study. All other doses of the extract 
produced inconsistent changes in the number 
of fecal pellets of the mice. The number of 
fecal pellets produced by CO got to its peak at 
the fourth hour of the study, while all the 
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doses of AAV used caused gradual increases 
in fecal pellet output throughout the study.  
 
Effects of AAV on the weight of fecal 
pellets 
All the doses of AAV produced 
significantly higher fecal pellet weights than 
NS throughout the study (Table 2). With CO, 
the pellet weight got to its peak at the 4th hour 
of the study, while all the doses of AAV 
produced gradual increases in fecal pellet 
weight. A dose of 200 mg/kg of AAV 
produced significantly higher pellet weight 
than CO between 6th and 24th hour of the 
study. It was only at the 24th hour of the study 
that 100 and 300 mg/kg of AAV produced a 
significantly higher pellet weight than CO. 
 
Effects of AAV on intestinal transit 
Doses of AAV caused more significant 
but not dose–dependent increases in intestinal 
transit than NS and CO up till 200 mg/kg 
(Table 3). At 300 mg/kg, intestinal transit was 
significantly lower than both in NS and CO. 
 
Effects of AAV on the number of fecal 
pellets following loperamide-induced 
constipation 
Following loperamide-induced 
constipation, CO produced significantly lower 
number of fecal pellets than NS in most part 
of the study, while 200 mg/kg of AAV 
produced significantly higher number of fecal 
pellets than CO (Table 4). The results indicate 
that AAV was able to reverse the loperamide- 
induced constipation better than CO. 
  
Effects of AAV on the weight of fecal 
pellets following loperamide-induced 
constipation 
Castor oil (CO) produced significantly 
lower fecal pellet weights than NS throughout 
the study, while 200 and 300 mg/kg of AAV 
produced significantly higher weights of fecal 
pellets than CO and significantly lower fecal 
pellet weights than NS in most parts of the 
study (Table 5). 200 mg/kg of AAV produced 
significantly higher fecal pellet weights than 
300 mg/kg in the first eight hours of the study. 
This indicates that the doses of AAV used in 
the study caused a more significant reversal of 
loperamide–induced constipation than CO in 
mice. The greater reversal was caused by 200 
mg/kg of the extract. 
 
Effects of some receptor blockers on the 
number of fecal pellets following 
administration of AAV 
Compared to NS, ATR produced a 
significantly lower number of fecal pellets 
only in the 2nd hour of the study (Table 6); 
CHL and PRO did the same up to the 6th and 
8th hours of the study respectively, while NIF 
did likewise throughout the study. HEX 
caused a more significant increase in fecal 
pellet number only in the 24th hour of the 
study. This indicates that the most effective 
blocker of the increased spontaneous 
defecation caused by AAV is NIF.  
 
Effects of some receptor blockers on the 
weight of fecal pellets following 
administration of AAV 
Compared to NS, ATR caused a 
significantly higher fecal pellet weight 
throughout the study, except in the 2nd hour 
when it was significantly lower (Table 7); 
CHL, PRO and NIF produced significantly 
lower fecal pellet weights throughout the 
study, while HEX produced significantly 
higher weights of fecal pellets throughout the 
experiment. NIF produced the most 
significant reduction in pellet weights, 
indicating that it is the most effective blocker 
of the increased fecal pellet output caused by 
AAV.
 




 Table 1: Effects of AAV on pellet number. 
 
2nd hr 4th hr 6th hr 8th hr 24th hr Dose 
No No No No No 
Nor mal. S. 2.80+0.84 5.00+0.71 5.80 + 0. 45 7.00+0.71 7.80+0.45 
Castor Oil 3.40+0.55 7.00+0.71aaa 7.00+0.71a 7.00+0.71 7.00+0.71 
50 mg/kg 3.80+0.45 5.80+0.45b 7.00+0.71a 7.40+0.55 8.40+0.55 
100 mg/kg 2.80+0.84 4.40+0.55bbb cc 5.40+0.55bb cc 5.80+0.45cc 9.80+1.30a bbb 
200 mg/kg 5.20+0.45aaa bbb cc ddd 6.20+0.45a ddd 9.40+0.55aaa bbb ccc ddd 11.00+0.71aaa bbb ccc ddd 12.60+0.55aaa bbb ccc ddd 
300 mg/kg 4.40+0.55aa dd 6.20+0.4a ddd 6.20+0.45 6.60+0.55 10.40+1.14aaa bbb c 
a = NS as reference (a = significant at p < 0.05; aa = significant at p < 0.01; aaa = significant at p < 0.001)  
b = CO as reference (b = significant at p < 0.05; bb = significant at p < 0.01; bbb = significant at p < 0.001) 
c = 50 mg/kg as reference (c = significant at p < 0.05; cc = significant at p < 0.01; ccc = significant at p < 0.001) 
d = 100 mg/kg as reference (d = significant at p < 0.05; dd = significant at p < 0.01; ddd = significant at p < 0.001) 
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Table 2: Effects of AAV on pellet weight. 
 
2nd hr  4th hr 6th hr 8th hr 24th hr Dose 
Wt (mg) Wt (mg) Wt (mg) Wt (mg) Wt (mg) 
Nor mal. Saline (NS) 28.00+.16 51.40+ 0.24 58.40+0.20 72.20+ 0.21 84.72+ 0.10 
Castor Oil (CO) 54.40+0.20 aaa  107.00+0.26aaa 107.00+0.26aaa  107.00+0.26aaa 107.00+0.11aaa 
50 mg/kg 44.56+0.22 aaa bbb  63.80+0.12aaa bbb 76.00+0.12aaa bbb 79.60+0.21aaa bbb 87.40+0.07aaa bbb 
100 mg/kg 49.00+0.35 aaa bbb ccc  63.20+0.20aaa bbb ccc 73.20+0.21aaa bbb ccc 96.60+0.24aaa bbb ccc 130.60+0.06aaa bbb ccc 
200 mg/kg 63.80+0.20 aaa bbb ccc ddd 75.40+0.14aaa bbb ccc ddd 110.00+0.12aaa bbb ccc ddd 122.00+0.24aaa bbb ccc ddd 125.20+0.09aaa bbb ccc ddd 
300 mg/kg 55.00+0.14aaa bbb ccc ddd eee 76.20+0.14aaa bbb ccc ddd eee 76.20+0.14aaa bbb ddd eee 79.60+0.14aaa bbb ddd eee 130.40+0.09aaa bbb ddd eee 
a = NS as reference (a = significant at p < 0.05; aa = significant at p < 0.01; aaa = significant at p < 0.001)  
b = CO as reference (b = significant at p < 0.05; bb = significant at p < 0.01; bbb = significant at p < 0.001) 
c = 50 mg/kg as reference (c = significant at p < 0.05; cc = significant at p < 0.01; ccc = significant at p < 0.001) 
d = 100 mg/kg as reference (d = significant at p < 0.05; dd = significant at p < 0.01; ddd = significant at p < 0.001) 
e = 200 mg/kg as reference (e = significant at p < 0.05; ee = significant at p < 0.01; eee = significant at p < 0.001). 
(n = 5). 
 
Table 3: Intestinal transit data. 
 
Group No of Points Mean Percentage Distance Travelled 
NS 5 36.99+0.13 
CO 5 48.63+0.23 aaa 
50 mg/kg 5 69.08+0.32aaa bbb 
100 mg/kg 5 53.15+0.22aaa bbb ccc 
200 mg/kg 5 86.55+0.37aaa bbb ccc ddd 
300 mg/kg 5 28.08+0.22aaa bbb ccc ddd eee 
a = NS as reference (a = significant at p < 0.05; aa = significant at p < 0.01; aaa = significant at p < 0.001)  
b = CO as reference (b = significant at p < 0.05; bb = significant at p < 0.01; bbb = significant at p < 0.001) 
c = 50 mg/kg as reference (c = significant at p < 0.05; cc = significant at p < 0.01; ccc = significant at p < 0.001) 
d = 100 mg/kg as reference (d = significant at p < 0.05; dd = significant at p < 0.01; ddd = significant at p < 0.001) 
e = 200 mg/kg as reference (e = significant at p < 0.05; ee = significant at p < 0.01; eee = significant at p < 0.001). 
(n=5). 
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Table 4: Effects of AAV on the number of fecal pellets following loperamide-induced constipation. 
 
2nd hr  4th hr 6th hr 8th hr 24th hr Dose 
No. No. No. No. No. 
Nor mal. S. 2.40+0.55 2.40+0.55 2.80 + 0. 45 3.00+0.00 6.00+1.23 
Castor Oil 0.40+0.55aaa 0.40+0.55aaa 0.40+0.55aaa 0.80+0.45aaa 4.80+0.45 
200 mg/kg 2.00+0.71bb 2.60+0.55bbb 3.00+0.00bbb 3.00+0.00bbb 8.00+1.00a bbb 
300 mg/kg 1.00+0.71a 1.00+0.71aa ee 1.00+0.71aaa eee 1.00+0.71aaa eee 8.20+1.10a bbb 
a = NS as reference (a = significant at p < 0.05; aa = significant at p < 0.01; aaa = significant at p < 0.001)  
b = CO as reference (b = significant at p < 0.05; bb = significant at p < 0.01; bbb = significant at p < 0.001) 




Table 5: Effects of AAV on the weight of fecal pellets following loperamide-induced constipation. 
 
2nd hr  4th hr 6th hr 8th hr 24th hr Dose 
Wt (mg) Wt (mg) Wt (mg) Wt (mg) Wt (mg) 
Nor mal. S. 33.18+0.13 76.68+ 0.19 37.42+0.22 40.10+ 0.16 85.86+ 0.30 
Castor Oil 7.16+0.17aaa 7.16+0.1aaa7 7.16+0.17aaa 15.98+0.15aaa 83.56+0.30aaa 
200 mg/kg 15.98+0.13aaa bbb 18.58+0.25aaa bbb 22.58+0.22aaa bbb 22.58+0.22aaa bbb 70.46+0.31aaa bbb 
300 mg/kg 9.56+0.15aaa bbb eee 9.56+0.15aaa bbb eee 9.56+0.15aaa bbb eee 9.56+0.15aaa bbb eee 107.20+0.37aaa bbb eee 
a = NS as reference (a = significant at p < 0.05; aa = significant at p < 0.01; aaa = significant at p < 0.001)  
b = CO as reference (b = significant at p < 0.05; bb = significant at p < 0.01; bbb = significant at p < 0.001) 
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 Table 6: Effects of some receptor blockers on the number of fecal pellets following administration of AAV. 
 
2nd hr  4th hr 6th hr 8th hr 24th hr Dose 
No. No. No. No. No. 
Nor mal. S. 7.40+0.55 7.60+0.55 7.60 + 0. 55 7.60+0.55 8.60+0.55 
ATR 5.80+1.10a 7.00+0.71 7.60+0.55 7.60+0.55 7.60+0.55 
CHL 5.00+1.00aaa 5.40+0.55aaa 6.00+0.00aaa 7.00+0.00 9.40+0.55 
PRO 5.40+0.85aa 5.40+0.55aaa 5.60+0.55aaa 5.60+0.55aaa 7.40+0.55 
NIF 3.40+0.55aaa 3.40+0.55aaa 4.40+0.55aaa 5.40+0.55aaa 5.40+0.55aaa 
HEX 6.60+0.55 7.00+0.00 8.00+0.71 8.00+0.71 10.00+1.00a 




  Table 7: Effects of some receptor blockers on the weight of fecal pellets following administration of AAV. 
 
2nd hr 4th hr 6th hr 8th hr 24th hr Dose 
Wt (mg) Wt (mg) Wt (mg) Wt (mg) Wt (mg) 
Nor mal. S. 78.14+0.24 83.20+ 0.26 83.20+0.26 83.20+ 0.26 98.06+ 0.31 
ATR 58.16+0.23aaa 93.78+0.20 aaa 104.74+0.48 aaa 104.74+0.48 aaa 104.74+0.48 aaa 
CHL 48.36+0.30 aaa 53.44+0.31 aaa 59.80+0.51 aaa 72.28+0.40 aaa 95.04+0.21 aaa 
PRO 68.40+0.53 aaa 68.40+0.53 aaa 72.46+0.40 aaa 72.46+0.40 aaa 94.62+0.45 aaa 
NIF 35.58+0.36 aaa 35.58+0.36 aaa 44.90+0.19 aaa 56.06+0.24 aaa 56.06+0.24 aaa 
HEX 92.24+0.17 aaa 98.62+0.51 aaa 112.40+0.51 aaa 125.60+0.41 aaa 140.00+0.51 aaa 
a = NS as reference ( aaa = significant at p < 0.001) (n=5). 
 




The effects of the doses of AAV used 
in this study (50–300 mg/kg) on the number 
of fecal pellets produced by the mice do not 
appear to be dose dependent. However, a dose 
of 200 mg/kg of the extract consistently 
produced significantly higher numbers of 
fecal pellets than NS throughout the study. It 
also produced higher number of fecal pellets 
than CO in most periods of the experiment 
(Table 1). Considering the weight of the 
pellets, all the doses of AAV produced 
significantly higher fecal pellet weights than 
NS throughout the study (Table 2). Again, its 
effect was not dose dependent. This is the first 
report of the effects of AAV on the output of 
feces in mice. The study showed that AAV 
facilitates defecation in mice by causing 
bigger pellets to be produced. The number and 
weight of fecal pellets produced by mice that 
received CO got to their peaks at the 4th hour 
of the observation period and remained 
unchanged throughout the rest of the period, 
while all the doses of AAV produced gradual 
increases in fecal pellet weights throughout 
the period of study. Some of the pellets 
produced by mice that received CO were 
actually wet. No wet feces was produced by 
the doses of AAV used in this study, A dose 
of 200 mg/kg of AAV produced significantly 
higher pellet weight than CO between 6th and 
24th hour of the study. It was only at the 24th 
hour of the study that 100 and 300 mg/kg of 
AAV produced a significantly higher pellet 
weight than CO. This could be as a result of 
the recovery of the mice from the influence of 
the extract.  At all other periods of the 
observation, the weights of the fecal pellets 
produced by mice that received the different 
doses of AAV were significantly lower than 
that of mice that got CO. Castor oil is known 
to cause water and electrolyte permeability 
changes in the intestinal mucosal membranes, 
resulting in fluid and watery luminal contents 
that flow rapidly through the small and large 
intestines (Gaginella et al., 1975; Mbagwu 
and Adeyemi, 2008). 
Since no wet feces were produced by 
the mice that were treated with AAV, it was 
concluded that the mechanisms by which 
AAV and CO caused increased fecal pellet 
output were not the same. That was the reason 
why we decided to investigate the mechanism 
of action of the extract using some receptor 
blockers. The non dose dependent effects of 
the extract on the parameters studied could be 
attributed to its toxicity in mice, as evident by 
tremor in some of the mice that received 300 
mg/kg, the highest dose of the extract used. 
Doses of AAV caused more significant 
but not dose–dependent increases in intestinal 
transit than NS and CO up till 200 mg/kg 
(Table 3). At 300 mg/kg, intestinal transit was 
significantly lower than both in NS and CO. 
This study indicates that AAV increases fecal 
pellet output of mice by increasing the rate of 
propulsive movement of their intestine. 
Chemical analysis of AAV indicates the 
presence of saponins and steroids. These 
substances may also be responsible for the 
increased propulsive movement caused by the 
extract. 
Throughout the observation period, 
mice that were pre-treated with loperamide 
produced significantly higher number of fecal 
pellets when treated with 200 mg/kg of AAV 
than those that were treated with CO, while 
those that were treated with 300 mg/kg of 
AAV produced significantly fewer fecal 
pellets than those treated with CO (Table 4). 
However, Table 5 shows that within the first 
eight hours of the study, both doses of AAV 
produced significantly greater fecal pellet 
weights than CO. The doses of AAV used in 
this study were able to reverse the loperamide-
induced constipation in mice better than CO. 
Loperamide inhibits gastrointestinal motility 
(propulsion), reduces intestinal fluid secretion 
and accumulation, and delays gastric 
emptying, while CO induces diarrhea and 
ameliorate constipation by causing water and 
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electrolyte permeability changes in the 
intestinal mucosal membranes, resulting in 
fluid and watery luminal contents that flow 
rapidly through the small and large intestines 
(Gaginella et al., 1975; Mbagwu and 
Adeyemi, 2008). Since the doses of AAV 
which were able to cause a significant reversal 
of the loperamide-induced constipation did 
not produce any wet feces even 24 hours after 
administration, the extract could serve as a 
better purgative than CO which induces 
defecation by increasing the secretory activity 
of the intestine. However, optimal absorption 
of nutrients requires adequate time of contact 
of digested food or chyme with the mucosa. 
Increased intestinal transit may reduce 
nutrient absorption by reducing the residence 
time of nutrients in the small intestine (Zhao 
et al., 1996). The increased intestinal transit 
induced by some doses of AAV could serve as 
a setback in exploring its use as a purgative.  
The number of fecal pellets was 
significantly lower than the control (NS) in 
mice that received CHL (up to the 6th hour), 
PRO (up to the 8th hour) and NIF (throughout 
the observation period) (Table 6). The pellet 
weights of the mice that received the three 
blockers (CHL, PRO and NIF) were 
significantly lower than that of the control 
mice throughout the study. The pellet weights 
of the mice that received the remaining two 
blockers, that is, ATR and HEX, were 
significantly higher than that of the control 
mice, except at the 2nd hour when it was 
significantly lower in mice that received ATR 
(Table 7). This study indicated that H1 
receptors and L type Ca2+ channels, are 
mainly involved in the increased fecal pellet 
output that was observed with the 
administration of AAV. Cholinergic receptors 
appear to play no significant role in the 
increased motility induced by AAV, as 
evidenced by the inability of ATR and HEX 
to block the effects of the extract. It is 
therefore concluded that AAV increases the 
peristaltic movement of the intestine of mice 
by stimulating H1 receptors and opening up of 
L type calcium channels along the lining of 
their intestine. The influence of AAV on 
calcium channels calls for caution in the 
consumption of Anaphe venata larvae and 
suggestive of its involvement in the seasonal 
ataxia often associated with its consumption 
in some parts of Nigeria.  
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